{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:08:44Z","timestamp":1787170124426,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.placenta.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T01:39:02Z","timestamp":1570239542000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Placental development and function in trisomy 21 and mouse models of Down syndrome: Clues for studying mechanisms underlying atypical development"],"prefix":"10.1016","volume":"89","author":[{"given":"April D.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faycal","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana W.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.placenta.2019.10.002_bib1","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1002\/ajmg.a.38402","article-title":"Estimation of live birth and population prevalence of Down syndrome in nine U.S. states","volume":"173","author":"de Graaf","year":"2017","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.placenta.2019.10.002_bib2","series-title":"Data and Statistics on Down Syndrome","year":"2017"},{"issue":"3","key":"10.1016\/j.placenta.2019.10.002_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance","volume":"18","author":"Antonarakis","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.placenta.2019.10.002_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/B978-0-444-54299-1.00002-9","article-title":"Genomic determinants in the phenotypic variability of Down syndrome","volume":"197","author":"Letourneau","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.placenta.2019.10.002_bib5","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1100\/tsw.2006.322","article-title":"Developmental defects in trisomy 21 and mouse models","volume":"6","author":"Delabar","year":"2006","journal-title":"Sci. World J."},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2788.2009.01158.x","article-title":"Down syndrome: a cardiovascular perspective","volume":"53","author":"Vis","year":"2009","journal-title":"J. Intellect. Disabil. Res."},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1152\/physrev.00029.2015","article-title":"Placental origins of chronic disease","volume":"96","author":"Burton","year":"2016","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.placenta.2019.10.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.11.014","article-title":"Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction","volume":"208","author":"von Beckerath","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.placenta.2019.10.002_bib9","first-page":"3700","article-title":"Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome","volume":"85","author":"Frendo","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.placenta.2019.10.002_bib10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3109\/14767058.2013.768982","article-title":"Senescence in amniocytes and placentas from trisomy 21 pregnancies","volume":"26","author":"Amiel","year":"2013","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"Suppl","key":"10.1016\/j.placenta.2019.10.002_bib11","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.placenta.2004.01.007","article-title":"Impact of trisomy 21 on human trophoblast behaviour and hormonal function","volume":"25","author":"Pidoux","year":"2004","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000264470","article-title":"Trisomy 21 placentas: histopathological and immunohistochemical findings using proliferating cell nuclear antigen","volume":"12","author":"Qureshi","year":"1997","journal-title":"Fetal Diagn. Ther."},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ajmg.a.30254","article-title":"Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway","volume":"130A","author":"Wright","year":"2004","journal-title":"Am. J. Med. Genet."},{"issue":"Suppl A","key":"10.1016\/j.placenta.2019.10.002_bib14","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1053\/plac.2001.0658","article-title":"Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome","volume":"22","author":"Massin","year":"2001","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2019.10.002_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pd.5054","article-title":"Antepartum management and obstetric outcomes among pregnancies with Down syndrome from diagnosis to delivery","volume":"37","author":"Guseh","year":"2017","journal-title":"Prenat. Diagn."},{"issue":"2","key":"10.1016\/j.placenta.2019.10.002_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ajmg.a.10823","article-title":"Poor outcome in Down syndrome fetuses with cardiac anomalies or growth retardation","volume":"116A","author":"Wessels","year":"2003","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/pd.4792","article-title":"Down syndrome: perinatal mortality risks with each additional week of expectant management","volume":"36","author":"Sparks","year":"2016","journal-title":"Prenat. Diagn."},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195905","article-title":"Confined placental mosaicism revisited: impact on pregnancy characteristics and outcome","volume":"13","author":"Toutain","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.placenta.2019.10.002_bib19","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/gim.2017.23","article-title":"Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes?","volume":"19","author":"Sparks","year":"2017","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.placenta.2019.10.002_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/pd.5340","article-title":"Pregnancy outcome of autosomal aneuploidies other than common trisomies detected by noninvasive prenatal testing in routine clinical practice","volume":"38","author":"Wan","year":"2018","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.placenta.2019.10.002_bib21","doi-asserted-by":"crossref","first-page":"32353","DOI":"10.1038\/srep32353","article-title":"An integrated human\/murine transcriptome and pathway approach to identify prenatal treatments for Down syndrome","volume":"6","author":"Guedj","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.placenta.2019.10.002_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168009","article-title":"Perinatal natural history of the Ts1Cje mouse model of Down syndrome: growth restriction, early mortality, heart defects, and delayed development","volume":"11","author":"Ferres","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.placenta.2019.10.002_bib23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis. Model Mech."},{"issue":"1","key":"10.1016\/j.placenta.2019.10.002_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0035-1570031","article-title":"Animal models to study placental development and function throughout normal and dysfunctional human pregnancy","volume":"34","author":"Grigsby","year":"2016","journal-title":"Semin. Reprod. Med."},{"issue":"2","key":"10.1016\/j.placenta.2019.10.002_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/scdb.2000.0156","article-title":"Genetic insights into trophoblast differentiation and placental morphogenesis","volume":"11","author":"Cross","year":"2000","journal-title":"Semin. Cell Dev. Biol."},{"issue":"Suppl A","key":"10.1016\/j.placenta.2019.10.002_bib26","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.placenta.2005.10.013","article-title":"Comparative placentation: some interesting modifications for histotrophic nutrition -- a review","volume":"27","author":"Enders","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2019.10.002_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.cellbio.24.110707.175418","article-title":"The evolution, regulation, and function of placenta-specific genes","volume":"24","author":"Rawn","year":"2008","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"2\u20133","key":"10.1016\/j.placenta.2019.10.002_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/plac.2002.0887","article-title":"Genes, development and evolution of the placenta","volume":"24","author":"Cross","year":"2003","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2019.10.002_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.placenta.2006.12.001","article-title":"Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta","volume":"28","author":"Burdon","year":"2007","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jsgi.2006.02.007","article-title":"Gene expression patterns in the developing murine placenta","volume":"13","author":"Gheorghe","year":"2006","journal-title":"J. Soc. Gynecol. Investig."},{"issue":"1","key":"10.1016\/j.placenta.2019.10.002_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/msb.2009.37","article-title":"Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology","volume":"5","author":"Cox","year":"2009","journal-title":"Mol. Syst. Biol."},{"issue":"1\u20132","key":"10.1016\/j.placenta.2019.10.002_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/19336918.2015.1120397","article-title":"Intrauterine trophoblast migration: a comparative view of humans and rodents","volume":"10","author":"Silva","year":"2016","journal-title":"Cell Adhes. Migrat."},{"issue":"3","key":"10.1016\/j.placenta.2019.10.002_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033294","article-title":"Differences in gene expression between first and third trimester human placenta: a microarray study","volume":"7","author":"Sitras","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1071-5576(02)00167-3","article-title":"Relationship between the extent of histologic villous mineralization and stillbirth in aneuploid and euploid fetuses","volume":"9","author":"Pierce","year":"2002","journal-title":"J. Soc. Gynecol. Investig."},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib35","first-page":"A90","article-title":"The incidence of hemorrhagic endovasculitis is increased in cases of both liveborn and stillborn trisomy 21","volume":"45","author":"Salafia","year":"1989","journal-title":"Am. J. Med. Genet. Suppl."},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/2005-129-0632-SWPHEA","article-title":"Stillbirths with placental hemorrhagic endovasculitis: a morphologic assessment with clinical implications","volume":"129","author":"Sander","year":"2005","journal-title":"Arch. Pathol. Lab Med."},{"issue":"7","key":"10.1016\/j.placenta.2019.10.002_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/plac.2000.0553","article-title":"Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies","volume":"21","author":"Roberts","year":"2000","journal-title":"Placenta"},{"issue":"12","key":"10.1016\/j.placenta.2019.10.002_bib38","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1210\/en.2011-1193","article-title":"Mesenchymal activin-A overcomes defective human trisomy 21 trophoblast fusion","volume":"152","author":"Gerbaud","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.placenta.2019.10.002_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-94-007-0782-5_4","article-title":"Human trophoblast in trisomy 21: a model for cell-cell fusion dynamic investigation","volume":"714","author":"Malassine","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Suppl","key":"10.1016\/j.placenta.2019.10.002_bib40","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.placenta.2011.11.007","article-title":"Review: human trophoblast fusion and differentiation: lessons from trisomy 21 placenta","volume":"33","author":"Pidoux","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2019.10.002_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7827-3-25","article-title":"A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies","volume":"3","author":"Banerjee","year":"2005","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.placenta.2019.10.002_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2393-14-197","article-title":"The utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy","volume":"14","author":"Chambers","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.placenta.2019.10.002_bib43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1126\/science.aaw7733","article-title":"IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise","volume":"365","author":"Buchrieser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.placenta.2019.10.002_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.placenta.2019.10.002_bib45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.placenta.2011.05.001","article-title":"How does variability of immune system genes affect placentation?","volume":"32","author":"Colucci","year":"2011","journal-title":"Placenta"},{"issue":"4 Suppl","key":"10.1016\/j.placenta.2019.10.002_bib46","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.placenta.2008.01.013","article-title":"Expression of keratin 8 and TNF-related apoptosis-I inducing ligand (TRAIL) in Down syndrome placentas","volume":"29","author":"Klugman","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2019.10.002_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.placenta.2018.03.003","article-title":"Oxidative stress in placental pathology","volume":"69","author":"Schoots","year":"2018","journal-title":"Placenta"},{"issue":"2\u20133","key":"10.1016\/j.placenta.2019.10.002_bib49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1387\/ijdb.082766am","article-title":"Trisomy 21- affected placentas highlight prerequisite factors for human trophoblast fusion and differentiation","volume":"54","author":"Malassine","year":"2010","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.placenta.2019.10.002_bib50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1749-6632.2002.tb04654.x","article-title":"Implication of copper zinc superoxide dismutase (SOD-1) in human placenta development","volume":"973","author":"Frendo","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2\u20133","key":"10.1016\/j.placenta.2019.10.002_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/plac.2001.0767","article-title":"Placental morphogenesis in pregnancies with Down's syndrome might provide a clue to pre-eclampsia","volume":"23","author":"Banerjee","year":"2002","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib52","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000001439","article-title":"Practice bulletin no. 163 summary: screening for fetal aneuploidy","volume":"127","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib53","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","article-title":"First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes","volume":"115","author":"Dugoff","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.placenta.2019.10.002_bib54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/pd.4609","article-title":"Evaluating first trimester maternal serum screening combinations for down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat. Diagn."},{"issue":"Suppl","key":"10.1016\/j.placenta.2019.10.002_bib55","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","article-title":"Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease","volume":"35","author":"Taglauer","year":"2014","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.placenta.2019.10.002_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/AOG.0000000000000145","article-title":"Obstetric, perinatal, and fetal outcomes in pregnancies with false-positive integrated screening results","volume":"123","author":"Baer","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.placenta.2019.10.002_bib57","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/(SICI)1097-0223(199710)17:10<941::AID-PD183>3.0.CO;2-G","article-title":"Biochemical markers of trisomy 21 and the pathophysiology of down's syndrome pregnancies","volume":"17","author":"Newby","year":"1997","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.placenta.2019.10.002_bib58","first-page":"35","article-title":"The hormones of the placenta","volume":"8","author":"Oratz","year":"2014","journal-title":"Sci. J. Lander Coll. Arts Sci."},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1373\/clinchem.2006.080614","article-title":"Quantification of proteolytically active pregnancy-associated plasma protein-A with an assay based on quenched fluorescence","volume":"53","author":"Gyrup","year":"2007","journal-title":"Clin. Chem."},{"issue":"2S","key":"10.1016\/j.placenta.2019.10.002_bib60","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1016\/j.ajog.2017.11.575","article-title":"A placenta clinic approach to the diagnosis and management of fetal growth restriction","volume":"218","author":"Kingdom","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2S","key":"10.1016\/j.placenta.2019.10.002_bib61","doi-asserted-by":"crossref","first-page":"S725","DOI":"10.1016\/j.ajog.2017.12.002","article-title":"Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers","volume":"218","author":"Gaccioli","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1\u20132","key":"10.1016\/j.placenta.2019.10.002_bib62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2005.07.028","article-title":"The role of the insulin-like growth factor system in prenatal growth","volume":"86","author":"Randhawa","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pd.4087","article-title":"Maternal serum placental growth factor and alpha-fetoprotein testing in first trimester screening for down syndrome","volume":"33","author":"Donalson","year":"2013","journal-title":"Prenat. Diagn."},{"issue":"7","key":"10.1016\/j.placenta.2019.10.002_bib64","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pd.4597","article-title":"First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-beta human chorionic gonadotrophin, placental growth factor, and alpha-fetoprotein","volume":"35","author":"Huang","year":"2015","journal-title":"Prenat. Diagn."},{"issue":"2\u20133","key":"10.1016\/j.placenta.2019.10.002_bib65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/plac.1999.0469","article-title":"Placental synthesis of oestriol in Down's syndrome pregnancies","volume":"21","author":"Newby","year":"2000","journal-title":"Placenta"},{"issue":"2\u20133","key":"10.1016\/j.placenta.2019.10.002_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/plac.2000.0598","article-title":"Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies","volume":"22","author":"Dalgliesh","year":"2001","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib67","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pd.53","article-title":"Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies","volume":"21","author":"Spencer","year":"2001","journal-title":"Prenat. Diagn."},{"issue":"11","key":"10.1016\/j.placenta.2019.10.002_bib68","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/pd.4194","article-title":"First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA","volume":"33","author":"Johnson","year":"2013","journal-title":"Prenat. Diagn."},{"issue":"2","key":"10.1016\/j.placenta.2019.10.002_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/pd.2904","article-title":"Maternal serum placental growth factor in second trimester trisomy 21 pregnancies","volume":"32","author":"Cowans","year":"2012","journal-title":"Prenat. Diagn."},{"issue":"2S","key":"10.1016\/j.placenta.2019.10.002_bib70","doi-asserted-by":"crossref","first-page":"S762","DOI":"10.1016\/j.ajog.2017.11.567","article-title":"Is there a role for placental senescence in the genesis of obstetric complications and fetal growth restriction?","volume":"218","author":"Sultana","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2019.10.002_bib71","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100849","article-title":"Molecular pathways of senescence regulate placental structure and function","author":"Gal","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.placenta.2019.10.002_bib72","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12530","article-title":"Usp16 contributes to somatic stem-cell defects in Down's syndrome","volume":"501","author":"Adorno","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.placenta.2019.10.002_bib73","doi-asserted-by":"crossref","first-page":"17506","DOI":"10.1038\/s41598-018-34562-w","article-title":"Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation","volume":"8","author":"Adorno","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.placenta.2019.10.002_bib74","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ajpath.2018.07.004","article-title":"Amyloid precursor protein overexpression in Down syndrome trophoblast reduces cell invasiveness and interferes with syncytialization","volume":"188","author":"Wong","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.placenta.2019.10.002_bib75","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/humrep\/dem214","article-title":"Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype","volume":"22","author":"Rozovski","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.placenta.2019.10.002_bib76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/35012518","article-title":"Chromosome 21 mapping and sequencing consortium. The DNA sequence of human chromosome 21","volume":"405","author":"Hattori","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.placenta.2019.10.002_bib77","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/pd.3826","article-title":"Expression of transcription factors controlling alpha inhibin gene expression in placental tissues from pregnancies affected by fetal Down syndrome","volume":"32","author":"Kipp","year":"2012","journal-title":"Prenat. Diagn."},{"issue":"9","key":"10.1016\/j.placenta.2019.10.002_bib78","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/pd.4862","article-title":"Placental transcriptomes in the common aneuploidies reveal critical regions on the trisomic chromosomes and genome-wide effects","volume":"36","author":"Bianco","year":"2016","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.placenta.2019.10.002_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2016.03.012","article-title":"Comprehensive investigation of DNA methylation and gene expression in trisomy 21 placenta","volume":"42","author":"Lim","year":"2016","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.placenta.2019.10.002_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003515","article-title":"Global DNA hypermethylation in Down syndrome placenta","volume":"9","author":"Jin","year":"2013","journal-title":"PLoS Genet."},{"issue":"3","key":"10.1016\/j.placenta.2019.10.002_bib81","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.placenta.2014.12.020","article-title":"Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome","volume":"36","author":"Lim","year":"2015","journal-title":"Placenta"},{"issue":"21\u201322","key":"10.1016\/j.placenta.2019.10.002_bib82","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.cca.2010.06.024","article-title":"Screening for adverse pregnancy outcome at early gestational age","volume":"411","author":"Hourrier","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.placenta.2019.10.002_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/pd.4370","article-title":"Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester","volume":"34","author":"Goetzinger","year":"2014","journal-title":"Prenat. Diagn."},{"issue":"11","key":"10.1016\/j.placenta.2019.10.002_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008010","article-title":"Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining","volume":"4","author":"Pennings","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2019.10.002_bib85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/pd.3829","article-title":"Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis","volume":"32","author":"Kang","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.placenta.2019.10.002_bib86","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/pd.2040","article-title":"Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma","volume":"28","author":"Kolialexi","year":"2008","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.placenta.2019.10.002_bib87","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1258\/ebm.2012.011312","article-title":"Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum","volume":"237","author":"Yu","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.placenta.2019.10.002_bib88","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1080\/14767058.2017.1319923","article-title":"Proteomic profile of serum of pregnant women carring a fetus with Down syndrome using nano uplc Q-tof ms\/ms technology","volume":"31","author":"Lopez Uriarte","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2019.10.002_bib89","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/pr060539h","article-title":"Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers","volume":"6","author":"Nagalla","year":"2007","journal-title":"J. Proteome Res."},{"issue":"22","key":"10.1016\/j.placenta.2019.10.002_bib90","first-page":"3738","article-title":"Proteomic analysis of the alteration of protein expression in the placenta of Down syndrome","volume":"124","author":"Sun","year":"2011","journal-title":"Chin. Med. J."},{"issue":"9","key":"10.1016\/j.placenta.2019.10.002_bib91","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1039\/c2mb25081k","article-title":"Placenta proteome analysis from Down syndrome pregnancies for biomarker discovery","volume":"8","author":"Chen","year":"2012","journal-title":"Mol. Biosyst."},{"issue":"6","key":"10.1016\/j.placenta.2019.10.002_bib92","article-title":"Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and dp(16)1\/yey mouse models of Down syndrome","volume":"11","author":"Aziz","year":"2018","journal-title":"Dis. Model Mech."},{"issue":"24","key":"10.1016\/j.placenta.2019.10.002_bib93","doi-asserted-by":"crossref","first-page":"E4753","DOI":"10.1073\/pnas.1702560114","article-title":"RNA-seq reveals conservation of function among the yolk sacs of human, mouse, and chicken","volume":"114","author":"Cindrova-Davies","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/tera.1420400514","article-title":"Altered placental morphology associated with murine trisomy 16 and murine trisomy 19","volume":"40","author":"Bersu","year":"1989","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.placenta.2019.10.002_bib95","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/j.1460-2075.1992.tb05094.x","article-title":"Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome","volume":"11","author":"Holtzman","year":"1992","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.placenta.2019.10.002_bib96","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/tera.1420450409","article-title":"Correlation of increased levels of class I MHC H-2Kk in the placenta of murine trisomy 16 conceptuses with structural abnormalities revealed by magnetic resonance microscopy","volume":"45","author":"Kornguth","year":"1992","journal-title":"Teratology"},{"key":"10.1016\/j.placenta.2019.10.002_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018866","article-title":"Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening","volume":"6","author":"Pennings","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2019.10.002_bib98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphys.2018.00373","article-title":"Development of the human placenta and fetal heart: synergic or independent?","volume":"9","author":"Burton","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.placenta.2019.10.002_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2019.03.016","article-title":"The placental atlas tool (PAT): a collaborative research and discovery platform for the placental research community","author":"Ilekis","year":"2019","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2019.10.002_bib100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.placenta.2014.02.012","article-title":"The human placenta project: placental structure, development, and function in real time","volume":"35","author":"Guttmacher","year":"2014","journal-title":"Placenta"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400419306745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400419306745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:00:57Z","timestamp":1758909657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400419306745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":100,"alternative-id":["S0143400419306745"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2019.10.002","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental development and function in trisomy 21 and mouse models of Down syndrome: Clues for studying mechanisms underlying atypical development","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}